Connaught Care And Bluecrest Wellness Lead The Charge On Men’s Health Through Ambitious ‘Movember’ Campaign

Photo Caption: Left: Connaught – Andrew Winstanley’s impressive moustache,
Right: Connaught – Andrew Winstanley and Iain Gordon

To cap off their efforts for ‘Movember 2024’, this week care home group Connaught Care Collection and employee health services provider Bluecrest Wellness celebrated raising over £2,000 to fight prostate cancer – well above the original target of £1,000. You can see the Just Giving page here.

Organised as a joint fundraising effort across both companies, all funds will go to supporting Prostate Cancer UK’s research, education, and support programs. Their efforts were led by Connaught Care’s CEO Andrew Winstanley and Finance Director Iain Gordon – who’s formidable moustaches inspired dozens of staff to join the fun!

Commenting on the success of the campaign, Andrew Winstanley said:
“Movember is a fantastic initiative which we are really proud to be taking part in with Bluecrest Wellness! This year, our mission was to help shine a spotlight on this terrible disease, which we know disproportionately affects older men in the UK. Unfortunately, for many people there is still a very real stigma around discussing these kinds of personal health issues; which can make recognising early symptoms and getting timely treatment difficult.”

Dominique Kent, CEO of Bluecrest Wellness, said:
“At Bluecrest, we’re passionate about making a difference. Until recently, more women than men booked annual health checks. But thanks to awareness efforts, October and November saw more men stepping up for health checks than ever before. A huge thank you to everyone who donated, supported, and shared the message. Together, we’re breaking barriers and changing lives.”

Led by the senior leadership teams at both companies, this collaboration was a passion project for staff who see the impact of prostate cancer every day.

Despite recent advances in the treatment of prostate cancer, it remains one of the most common forms of the disease amongst men. It accounts for about 28% of all male cancer cases from 2017–2019, and causes around 12,000 deaths each year in the UK. Sadly, incidence of the disease also seems to increase with age, with the highest rates in the 75–79 age group.